GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green in 2025 as of the Apr. 21 ...

In the December quarter, the company's management said it plans to double the firm's pen capacity over the next couple of ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

That drug is orforglipron, Eli Lilly’s GLP-1 drug that patients administer orally rather than through an injectable pen. The results of orforglipron’s Phase 3 Food and Drug Administration (FDA ...

Most GLP-1 drugs used for weight loss ... Its injectable drugs require both specialized injection pens and cold storage and shipping, so manufacturing and transport are often complex.

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...